The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Novel toxicity endpoint for dose-finding designs evaluating molecularly targeted agents (MTA).
Monia Ezzalfani
No relevant relationships to disclose
Sarah Zohar
No relevant relationships to disclose
Sumithra J. Mandrekar
No relevant relationships to disclose
Gilles Vassal
No relevant relationships to disclose
Marie-Cécile Le Deley
No relevant relationships to disclose